The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: A retrospective analysis of a contemporary series

The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: A retrospective analysis of a contemporary series

Show other versions (1)

Bibliographic Details
Main Authors:	M. Marchioni, R. Campi, A. Minervini, T. Klatte, M. Kriegmair, S. Erdem, U. Capitanio, E. Roussel, M. Albertsen, M. Heck, F. Porpiglia, S. Van Bruwaene, E. Linares, V. Hevia, M. Musquera, I. Derweesh, R. Autorino, N. Pavan, A. Antonelli, J. Rubio-Briones, A. Vecchia, E. Checcucci, F. Claps, M.C. Mir
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S266616832033439X

Similar Items

The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: a retrospective analysis of a contemporary series
by: M. Marchioni, et al.
Published: (2020-10-01)

Performance of a new risk assessment tool for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the targeted therapy era: REMARCC score
by: M.C. Mir Maresma, et al.
Published: (2020-07-01)

Predictors for perioperative complications in cytoreductive nephrectomy: Analysis of the registry for metastatic RCC (REMARCC)
by: E. Roussel, et al.
Published: (2020-07-01)

Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
by: Margaret F. Meagher, et al.
Published: (2024-05-01)

Proposal for a two-tier re-classification of stage IV/M1 renal cell carcinoma into M1 (oligometastatic) and M2 (polymetastatic) sub stages
by: M.F. Meagher, et al.
Published: (2020-07-01)

Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry
by: M.F. Meagher, et al.
Published: (2020-07-01)

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
by: Margaret F. Meagher, et al.
Published: (2023-03-01)

The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature
by: Hana Studentova, et al.
Published: (2022-08-01)

Clinical, surgical, pathological and follow-up features of kidney cancer in patients with von hippel-lindau syndRoma: novel insights from a large european consortium
by: U. Capitanio, et al.
Published: (2020-10-01)

Clinical, surgical, pathological and follow-up features of kidney cancer in patients with Von Hippel-Lindau syndrome: Novel insights from a large European consortium
by: U. Capitanio, et al.
Published: (2020-07-01)

Outcome benefits of upfront cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: An analysis of the TriNetX database.
by: Gu-Shun Lai, et al.
Published: (2024-01-01)

Establishment and validation of a nomogram to select patients with metastatic sarcomatoid renal cell carcinoma suitable for cytoreductive radical nephrectomy
by: Yulin Zhou, et al.
Published: (2023-10-01)

Robot-assisted partial nephrectomy for completely endophytic renal tumors: A multicenter outcome analysis
by: U. Carbonara, et al.
Published: (2020-10-01)

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)
by: Koen P. Rovers, et al.
Published: (2019-04-01)

Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
by: Renate Pichler, et al.
Published: (2019-03-01)

Primary adrenal sarcomatoid carcinoma
by: Aftab S. Shaikh, et al.
Published: (2014-03-01)

AL AMYLOIDOSIS UPFRONT TREATMENT AND CURRENT AND FUTURE STUDIES
by: E. Kastritis
Published: (2023-05-01)

New-onset Chronic Kidney Disease After Surgery for Localised Renal Masses in Patients with Two Kidneys and Preserved Renal Function: A Contemporary Multicentre Study
by: Alessio Pecoraro, et al.
Published: (2023-06-01)

Sarcomatoid carcinoma of the bladder after ileocystoplasty
by: A W Shindel, et al.
Published: (2006-01-01)

Urology Residency Training at the Time of COVID-19 in Italy: 1 Year After the Beginning
by: Daniele Amparore, et al.
Published: (2021-09-01)

Sarcomatoid urothelial carcinoma
by: Orelvys González Otaño, et al.
Published: (2012-04-01)

Sarcomatoid carcinoma of the cervix
by: Tahani H. Nageeti, et al.
Published: (2012-09-01)

Sarcomatoid hepatocellular carcinoma in a young African female
by: Abid M Sadiq, et al.
Published: (2021-10-01)

DEBATE UPFRONT vs DELAYED TRANSPLANT
by: F. Gay
Published: (2023-05-01)

Comparative analysis of functional outcomes of open and minimally invasive partial nephrectomy stratified by tumor complexity: A multi-center study
by: F. Ghali, et al.
Published: (2020-07-01)

Cytoreductive interventions in combination with hyperthermic intraperitoneal chemoperfusion in pseudomyxoma
by: A. G. Abdullayev, et al.
Published: (2014-08-01)

Sarcomatoid change in intrahepatic cholangiocarcinoma
by: Albrechtsen Wewer Nicolai, et al.
Published: (2013-03-01)

SARCOMATOID CHANGE IN INTRAHEPATIC CHOLANGIOCARCINOMA
by: Wewer Albrechtsen, et al.
Published: (2013-01-01)

Immunophenotyping of pulmonary sarcomatoid carcinoma
by: Yu Ma, et al.
Published: (2022-10-01)

Sarcomatoid carcinoma of the larynx and hypopharynx
by: Ercan Pınar, et al.
Published: (2004-12-01)

Extralobular sarcomatoid carcinoma of the lung
by: Shi-Min Yuan, et al.
Published: (2014-07-01)

Sarcomatoid renal cell carcinoma
by: Kafil Akhtar, et al.
Published: (2011-01-01)

Immunohistochemistry for Claudin-4 and BAP1 in the Differential Diagnosis between Sarcomatoid Carcinoma and Sarcomatoid Mesothelioma
by: Lina Zuccatosta, et al.
Published: (2023-01-01)

Clinical outcomes of low-stage sarcomatoid renal cell carcinoma
by: A. Abello, et al.
Published: (2020-07-01)

Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome
by: Maria Gavriatopoulou, et al.
Published: (2020-06-01)

Upfront radiotherapy for diffuse lymphangiomatosis in a child
by: Abhishek Purkayastha, et al.
Published: (2016-01-01)

The significance of sarcomatoid and rhabdoid dedifferentiation in renal cell carcinoma
by: Andrew W. Hahn, et al.
Published: (2022-01-01)

Upfront hypofractionated frameless Gamma Knife radiosurgery for large posterior fossa metastases
by: Y. Samanci, et al.
Published: (2022-01-01)

Quaternary and beyond cytoreduction: An updated and expanded analysis
by: Beryl L. Manning-Geist, et al.
Published: (2021-08-01)

Lymph node dissection is associated with decreased survival and all cause mortality among patients undergoing cytoreductive nephrectomy for metastatic renal cell carcinoma
by: S. Weprin, et al.
Published: (2020-07-01)